SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
10-Q	Quarterly report which provides a continuing view of a company's financial position	Nov 6, 2003	View HTML 0001104659-03-024908.pdf 0001104659-03-024908.rtf 0001104659-03-024908.xls
S-3/A	Pre-effective amendment to an S-3 filing	Nov 7, 2003	View HTML 0001047469-03-036404.pdf 0001047469-03-036404.rtf 0001047469-03-036404.xls
5	Annual filing director officer or owner of more than ten percent.	Jan 5, 2004	View HTML 0001179110-04-000156.pdf 0001179110-04-000156.rtf 0001179110-04-000156.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000245.pdf 0001179110-04-000245.rtf 0001179110-04-000245.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000250.pdf 0001179110-04-000250.rtf 0001179110-04-000250.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000257.pdf 0001179110-04-000257.rtf 0001179110-04-000257.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000265.pdf 0001179110-04-000265.rtf 0001179110-04-000265.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000270.pdf 0001179110-04-000270.rtf 0001179110-04-000270.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2004	View HTML 0001179110-04-000277.pdf 0001179110-04-000277.rtf 0001179110-04-000277.xls
4	Statement of changes in beneficial ownership of securities	Jan 7, 2004	View HTML 0001179110-04-000636.pdf 0001179110-04-000636.rtf 0001179110-04-000636.xls

Data provided by Kaleidoscope.